A Novel Ornithine Aminotransferase Splice Site Mutation Causes Vitamin B6-Responsive Gyrate Atrophy

Abstract Purpose: Gyrate atrophy of the choroid and retina (GACR) is a rare congenital disorder and mutations in the ornithine aminotransferase (OAT) gene has been specified as the underlying cause. Patients show a high level of ornithine in body fluids which may be controlled by low protein diets....

Full description

Bibliographic Details
Main Authors: Samira Molaei Ramshe, Safoura Zardadi, Elham Alehabib, Ramin Nourinia, Javad Jamshidi, Mohsen Soosanabadi, Hossein Darvish
Format: Article
Language:English
Published: Knowledge E 2024-03-01
Series:Journal of Ophthalmic & Vision Research
Subjects:
Online Access:https://doi.org/10.18502/jovr.v19i1.15446
_version_ 1827299156566212608
author Samira Molaei Ramshe
Safoura Zardadi
Elham Alehabib
Ramin Nourinia
Javad Jamshidi
Mohsen Soosanabadi
Hossein Darvish
author_facet Samira Molaei Ramshe
Safoura Zardadi
Elham Alehabib
Ramin Nourinia
Javad Jamshidi
Mohsen Soosanabadi
Hossein Darvish
author_sort Samira Molaei Ramshe
collection DOAJ
description Abstract Purpose: Gyrate atrophy of the choroid and retina (GACR) is a rare congenital disorder and mutations in the ornithine aminotransferase (OAT) gene has been specified as the underlying cause. Patients show a high level of ornithine in body fluids which may be controlled by low protein diets. Pyridoxine (vitamin B6) supplementation may also be effective, however, most patients appear to be nonresponsive to this modality of treatment. Case Report: Here, we report a characterized case of a vitamin B6-responsive GACR who had a splicing mutation in the OAT gene. The GACR diagnosis was confirmed through the clinical features, imaging, biochemical findings, and whole-exome sequencing (WES) results. WES data revealed the splicing mutation in intron 4 of the OAT gene (NM_001322967: c.425-1G > A). Conclusion: Our knowledge about the diagnosis and treatment of GACR can be improved by identifying novel mutations in the OAT gene and accurate follow-up of the patients to determine how they respond to treatment.
first_indexed 2024-04-24T15:28:08Z
format Article
id doaj.art-be511fcce9894a3cba160f58b3d04c22
institution Directory Open Access Journal
issn 2008-2010
2008-322X
language English
last_indexed 2024-04-24T15:28:08Z
publishDate 2024-03-01
publisher Knowledge E
record_format Article
series Journal of Ophthalmic & Vision Research
spelling doaj.art-be511fcce9894a3cba160f58b3d04c222024-04-02T05:30:46ZengKnowledge EJournal of Ophthalmic & Vision Research2008-20102008-322X2024-03-0119111813210.18502/jovr.v19i1.15446jovr.v19i1.15446A Novel Ornithine Aminotransferase Splice Site Mutation Causes Vitamin B6-Responsive Gyrate AtrophySamira Molaei Ramshe0Safoura Zardadi1Elham Alehabib2Ramin Nourinia3Javad Jamshidi4Mohsen Soosanabadi5Hossein Darvish6 Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA Department of Biology, School of Basic Sciences, Science and Research Branch, Islamic Azad University, Tehran, Iran Student Research Committee, Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran Department of Medical Genetics, Semnan University of Medical Sciences, Semnan, Iran Neuroscience Research Center, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, IranAbstract Purpose: Gyrate atrophy of the choroid and retina (GACR) is a rare congenital disorder and mutations in the ornithine aminotransferase (OAT) gene has been specified as the underlying cause. Patients show a high level of ornithine in body fluids which may be controlled by low protein diets. Pyridoxine (vitamin B6) supplementation may also be effective, however, most patients appear to be nonresponsive to this modality of treatment. Case Report: Here, we report a characterized case of a vitamin B6-responsive GACR who had a splicing mutation in the OAT gene. The GACR diagnosis was confirmed through the clinical features, imaging, biochemical findings, and whole-exome sequencing (WES) results. WES data revealed the splicing mutation in intron 4 of the OAT gene (NM_001322967: c.425-1G > A). Conclusion: Our knowledge about the diagnosis and treatment of GACR can be improved by identifying novel mutations in the OAT gene and accurate follow-up of the patients to determine how they respond to treatment.https://doi.org/10.18502/jovr.v19i1.15446gyrate atrophy mutation ornithine aminotransferase vitamin b6
spellingShingle Samira Molaei Ramshe
Safoura Zardadi
Elham Alehabib
Ramin Nourinia
Javad Jamshidi
Mohsen Soosanabadi
Hossein Darvish
A Novel Ornithine Aminotransferase Splice Site Mutation Causes Vitamin B6-Responsive Gyrate Atrophy
Journal of Ophthalmic & Vision Research
gyrate atrophy mutation ornithine aminotransferase vitamin b6
title A Novel Ornithine Aminotransferase Splice Site Mutation Causes Vitamin B6-Responsive Gyrate Atrophy
title_full A Novel Ornithine Aminotransferase Splice Site Mutation Causes Vitamin B6-Responsive Gyrate Atrophy
title_fullStr A Novel Ornithine Aminotransferase Splice Site Mutation Causes Vitamin B6-Responsive Gyrate Atrophy
title_full_unstemmed A Novel Ornithine Aminotransferase Splice Site Mutation Causes Vitamin B6-Responsive Gyrate Atrophy
title_short A Novel Ornithine Aminotransferase Splice Site Mutation Causes Vitamin B6-Responsive Gyrate Atrophy
title_sort novel ornithine aminotransferase splice site mutation causes vitamin b6 responsive gyrate atrophy
topic gyrate atrophy mutation ornithine aminotransferase vitamin b6
url https://doi.org/10.18502/jovr.v19i1.15446
work_keys_str_mv AT samiramolaeiramshe anovelornithineaminotransferasesplicesitemutationcausesvitaminb6responsivegyrateatrophy
AT safourazardadi anovelornithineaminotransferasesplicesitemutationcausesvitaminb6responsivegyrateatrophy
AT elhamalehabib anovelornithineaminotransferasesplicesitemutationcausesvitaminb6responsivegyrateatrophy
AT raminnourinia anovelornithineaminotransferasesplicesitemutationcausesvitaminb6responsivegyrateatrophy
AT javadjamshidi anovelornithineaminotransferasesplicesitemutationcausesvitaminb6responsivegyrateatrophy
AT mohsensoosanabadi anovelornithineaminotransferasesplicesitemutationcausesvitaminb6responsivegyrateatrophy
AT hosseindarvish anovelornithineaminotransferasesplicesitemutationcausesvitaminb6responsivegyrateatrophy
AT samiramolaeiramshe novelornithineaminotransferasesplicesitemutationcausesvitaminb6responsivegyrateatrophy
AT safourazardadi novelornithineaminotransferasesplicesitemutationcausesvitaminb6responsivegyrateatrophy
AT elhamalehabib novelornithineaminotransferasesplicesitemutationcausesvitaminb6responsivegyrateatrophy
AT raminnourinia novelornithineaminotransferasesplicesitemutationcausesvitaminb6responsivegyrateatrophy
AT javadjamshidi novelornithineaminotransferasesplicesitemutationcausesvitaminb6responsivegyrateatrophy
AT mohsensoosanabadi novelornithineaminotransferasesplicesitemutationcausesvitaminb6responsivegyrateatrophy
AT hosseindarvish novelornithineaminotransferasesplicesitemutationcausesvitaminb6responsivegyrateatrophy